Live Breaking News & Updates on Major Adverse Cardiovascular Events

Stay updated with breaking news from Major adverse cardiovascular events. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to Dr. Quigley, who addresses the importance of identifying and reducing residual inflammatory risk. ....

United States , Robertl Quigley , Acta Pharmacologica Sinica , Coll Cardiol , A Report From The American Heart Association , Jefferson Health System Phil , International Corporate Health Leadership Council , Drug Administration , American Heart Association , Jefferson Medical College , Residual Inflammatory , Trials Support Impact , Americas Region , Jefferson Health System , Jefferson Medical , Primary Prevention , Cardiovascular Disease , American College , American Heart Association Task Force , Clinical Practice Guidelines , Cardiovascular Diseases , Risk Factors , Update From , Accessed November , Major Adverse Cardiovascular Events , Patients With Established Atherosclerotic Disease ,

Testosterone Replacement Therapy Not Linked to Prostate Cancer Incidence

Testosterone replacement therapy vs placebo was not associated with a higher incidence of prostate cancer among men with hypogonadism. ....

International Prostate Symptom Score , Testosterone Replacement Therapy , Major Adverse Cardiovascular Events , Efficacy Measures , Hypogonadal Men ,

Study Finds No Protective Benefit against Retinopathy with Omega-3 Fatty Acids

A substudy of the ASCEND trial offers insight into the effects of omega-3 fatty acids use on risk of diabetic retinopathy in people with diabetes. ....

United Kingdom , Jane Armitage , United Kingdom National Screening Committee , Study Collaborative Group , Oxford Population Health Jane Armitage , Diabetic Eye Screening Program , Nuffield Department Of Public Health , Oxford Population Health , Cardiovascular Events , Nuffield Department , Public Health , Eye Screening Program , United Kingdom National Screening , Standard Deviation , Risk Reduction , Icosapent Ethyl , Corn Oil , Major Adverse Cardiovascular Events , High Cardiovascular Risk , Collaborative Group , Acid Supplements , Contemp Clin Trials ,

#VisualAbstract: Pitavastatin reduces cardiovascular event risk among patients with HIV

1. In this randomized controlled trial, among patients living with human immunodeficiency virus (HIV) at low-to-moderate risk of cardiovascular disease, pitavastatin calcium was superior to placebo in reducing the risk of a major adverse cardiovascular event (MACE). 2. The trial was stopped early due to evidence of the efficacy and safety of pitavastatin. Evidence Rating ....

United States , American College Of Cardiology , American Heart Association , Minute Medicine Inc , Rating Level , American College , Confidence Interval , Anti Retroviral Therapy , Chronic Disease , Infectious Disease , Major Adverse Cardiovascular Events , Public Health ,

SHL Telemedicine's SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 Conference

TEL AVIV, Israel & ZURICH & NEW YORK, September 11, 2023 SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that initial results from trials conducted by the Mayo Clinic (as part of a previously announced collaboration) and by Imperial College London will be featured in two upcoming presentations at the Imperial Vulnerable Plaque and Patient Meeting 2023 (VPM). Both tria ....

City Of , United Kingdom , Erez Nachtomy , Naseer Alshahrani , Joerg Hermann , Ramzi Khamis , Swiss Exchange , Nasdaq Stock Exchange , Imperial College London , Acute Coronary Syndrome , Mayo Clinic , Major Adverse Cardiovascular Events , Vulnerable Plaque , Patient Meeting , Heart Attack , Mayo Clinic , Telemedicine Solutions , Initial Results , Vulnerable Plaque ,